✦ LIBER ✦

Evaluation of the Metabolic Syndrome in Hypertensive Patients: Results From the ICEBERG Study

✍ Scribed by Giray Kabakci; Nevrez Koylan; Omer Kozan; Kemalettin Buyukozturk; Baris Ilerigelen

Book ID: 114773776
Publisher: Wiley (Blackwell Publishing)
Year: 2007
Tongue: English
Weight: 199 KB
Volume: 2
Category: Article
ISSN: 1559-4564
DOI: 10.1111/j.1559-4564.2007.06530.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVALUATION OF ROUTINE TESTS FOR HYPERTEN

EVALUATION OF ROUTINE TESTS FOR HYPERTENSIVE PATIENTS AT PRIMARY HEALTH CARE SETTINGS: RESULTS FROM THE ICEBERG STUDY

✍ Koylan, N.; Kozan, O.; Ilerigelen, B.; Kabakci, G.; Buyukozturk, K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

The impact of microalbuminuria measured

The impact of microalbuminuria measured by qualitative or quantitative methods on risk evaluation in hypertensive patients: Results from ICEBERG study

✍ Giray Kabakci; Nevrez Koylan; Kemalettin Buyukozturk; Baris Ilerigelen; Omer Koz 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

High doses of lercanidipine are better t

High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study

✍ V. Barrios; C. Escobar; M. De La Figuera; J. Honorato; J. L. Llisterri; J. Segur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

T04-P-008 The impact of hs-crp on risk e

T04-P-008 The impact of hs-crp on risk evaluation in hypertensive patients: Lessons learned from iceberg study

✍ Buyukozturk, K.; Ilerigelen, B.; Kabakci, G.; Koylan, N.; Kozan, O. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB

H 031 THE PREVALENCE OF METABOLIC SYNDRO

H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES

✍ Martin, José Fernando Vilela; Abdo, André Néder Ramires; Kuniyoshi, Cristina Hir 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Olmesartan/amlodipine vs olmesartan/hydr

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

✍ Martinez-Martin, F J; Rodriguez-Rosas, H; Peiro-Martinez, I; Soriano-Perera, P; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 427 KB

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients with metabolic syndrome (MetS). A total of 120 patients with MetS an